Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice

Nephrology Dialysis Transplantation

Volumn 28, Issue 6, 2013, Pages 1434-1439

  Veldink, Hendrik ^a   Faulhaber Walter, Robert ^a   Park, Joon Keun ^a   Martens Lobenhoffer, Jens ^b   Bode Böger, Stefanie ^b   Schuett, Harald ^a   Haghikia, Arash ^a   Hilfiker Kleiner, Denise ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Blood pressure; Ejection fraction; Glomerular filtration rate; SDMA

Indexed keywords

6 N,N' DIMETHYLARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G),N(G) DIMETHYLARGININE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HEART FUNCTION; KIDNEY FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

BLOOD PRESSURE; EJECTION FRACTION; GLOMERULAR FILTRATION RATE; SDMA;

ANIMALS; ARGININE; BLOOD PRESSURE; ECHOCARDIOGRAPHY; GLOMERULAR FILTRATION RATE; IMMUNOENZYME TECHNIQUES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III;

EID: 84879866787     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs554     Document Type: Article

References (25)

1. Kakimoto Y, Akazawa S. Isolation and identification of N-G,NG- and N-G,N'-G-dimethyl-arginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem 1970; 245: 5751-5758
2. Vallance, Leone A, Calver A et al. Accumulation of endogenous inhibitor of nictric oxide synthesis in chronic renal failure. Lancet 1992; 339: 572-575
3. Cooke JP. Asymmetrical dimethylarginine: the Uber marker? Circulation 2004; 109: 1813-1818
4. Zoccali C, Bode-Boger S, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 2001; 358: 2113-2117
5. Kielstein JT, Bode-Boger SM, Hesse G et al. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol 2005; 25: 1414-1418
6. Meinitzer A, Seelhorst U, Wellnitz B et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 2007; 53: 273-283
7. McDermott JR. Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J 1976; 154: 179-184
8. Nijveldt RJ, Van Leeuwen PA, Van Guldener C et al. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 2002; 17: 1999-2002
9. Kielstein JT, Salpeter SR, Bode-Boeger SM et al. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function- A meta-analysis. Nephrol Dial Transplant 2006; 21: 2446-2451
10. Kielstein JT, Martens-Lobenhoffer J, Vollmer S et al. L-Arginine, ADMA, SDMA, creatinine, MDRD formula: detour to renal function testing. J Nephrol 2008; 21: 959-961
11. Schwedhelm E, Xanthakis V, Maas R et al. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort. Clin Chem Lab Med 2011; 49: 1907-1910
12. Kielstein JT, Veldink H, Martens-Lobenhoffer J et al. SDMA is an early marker of change in GFR after living-related kidney donation. Nephrol Dial Transplant 2011; 26: 324-328
13. Kielstein JT, Fliser D, Veldink H. Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 2009; 22: 346-350
14. Bode-Boger SM, Scalera F, Kielstein JT et al. Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. J Am Soc Nephrol 2006; 17: 1128-1134
15. Luneburg N, von Holten RA, Topper RF et al. Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function. Clin Sci (Lond) 2012; 122: 105-111
16. Schulze F, Carter AM, Schwedhelm E et al. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. Atherosclerosis 2010; 208: 518-523
17. Schepers E, Glorieux G, Dhondt A et al. Role of symmetric dimethylarginine in vascular damage by increasing ROS via storeoperated calcium influx in monocytes. Nephrol Dial Transplant 2009; 24: 1429-1435
18. Schepers E, Barreto DV, Liabeuf S et al. Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 2374-2383
19. Hilfiker-Kleiner D, Kaminski K, Kaminska A et al. Regulation of proangiogenic factor CCN1 in cardiac muscle: impact of ischemia, pressure overload, and neurohumoral activation. Circulation 2004; 109: 2227-2233.
20. Qi Z, Whitt I, Mehta A et al. Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. Am J Physiol Renal Physiol 2004; 286: F590-F596
21. Martens-Lobenhoffer J, Bode-Boger SM. Fast and efficient determination of arginine, symmetric dimethylarginine, and asymmetric dimethylarginine in biological fluids by hydrophilicinteraction liquid chromatography-electrospray tandem mass spectrometry. Clin Chem 2006; 52: 488-493
22. Suda O, Tsutsui M, Morishita T et al. Asymmetric dimethylarginine produces vascular lesions in endothelial nitric oxide synthase-deficient mice: involvement of renin-angiotensin system and oxidative stress. Arterioscler Thromb Vasc Biol 2004; 24: 1682-1688
23. Closs EI, Basha FZ, Habermeier A et al. Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1997; 1: 65-73
24. Tojo A, Welch WJ, Bremer V et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 1997; 52: 1593-1601
25. Teerlink T, Luo Z, Palm F et al. Cellular ADMA: regulation and action. Pharmacol Res 2009; 60: 448-460